Muscle protein alterations in LGMD2I patients with different mutations in the Fukutin-related protein gene

Lydia U Yamamoto1, Fernando J Velloso, Bruno L Lima

  • 1Human Genome Research Center, Biosciences Institute, University of São Paulo, São Paulo, Brazil.

Insights

Mutations in the Fukutin-related protein (FKRP) gene cause Limb-Girdle muscular dystrophy Type 2I (LGMD2I). FKRP gene mutations lead to secondary reductions in muscle proteins, notably alpha-2-laminin and alpha-DG.

Area of Science:

  • Muscle Biology
  • Genetics
  • Neuromuscular Disorders

Background:

  • Fukutin-related protein (FKRP) is crucial for glycosylation of cell surface molecules.
  • Pathogenic FKRP gene mutations cause congenital muscular dystrophy Type 1C and Limb-Girdle muscular dystrophy Type 2I (LGMD2I).

Purpose of the Study:

  • To investigate muscle histological alterations and protein changes in LGMD2I patients.
  • To analyze the impact of different FKRP mutations on muscle protein expression.

Main Methods:

  • Muscle biopsies from 13 unrelated LGMD2I patients with 10 distinct FKRP mutations were analyzed.
  • Histological examination and immunofluorescence/Western blot analysis of 11 muscle proteins were performed.

Main Results:

  • A typical dystrophic pattern was observed in all patients, with rimmed vacuoles in eight.
  • Variable alpha-2-laminin deficiency (12/13 patients) and alpha-DG deficiency (10/13 patients) were prevalent.
  • Secondary deficiencies in calpain 3 (4/13) and dystrophin (2/13) were also detected.

Conclusions:

  • FKRP gene mutations in LGMD2I patients are associated with secondary reductions in multiple muscle proteins.
  • Deficiencies of alpha-2-laminin and alpha-DG are common in LGMD2I, irrespective of mutation type or clinical severity.